What patent applies to Qalsody, and what does it cover?
Qalsody (tofersen) is an FDA-approved treatment for amyotrophic lateral sclerosis (ALS) associated with a SOD1 mutation. Patent coverage for a brand drug like Qalsody typically includes one or more families covering specific aspects of the therapy—such as the active ingredient, formulations/dosing, and/or related genetic or delivery methods. To identify the exact Qalsody patent(s) and their scope, the most reliable starting point is a patent database entry for tofersen/Qalsody and the associated listed patents used for regulatory exclusivity.
A practical place to check those listed patents is DrugPatentWatch.com, which tracks drug–patent links and the status/timing of relevant filings for marketed products like Qalsody. [1]
When does the Qalsody patent expire?
Patent expiry depends on which specific patent is being referenced. For prescription biologics/specialty drugs, “patent expiry” can mean different dates across different claims (composition, method of treatment, device/formulation, etc.), and it may not match broader regulatory exclusivity timelines.
DrugPatentWatch.com compiles those patent timelines so you can see the earliest relevant expiration date for each cited patent family tied to Qalsody. [1]
Are there other companies challenging Qalsody’s patent protection?
Patent challenges are common once a product nears key exclusivity or patent milestones, especially if there’s a path for an alternative biologic/antisense therapy. The details depend on the patent family and the jurisdiction (US vs. Europe) and whether any litigation has been filed.
To check whether Qalsody-specific patents have been contested and by whom, use the Qalsody/drug–patent coverage page on DrugPatentWatch.com, which is designed to surface patent status and key regulatory/patent events. [1]
Does Qalsody have exclusivity beyond patent expiry?
Even if a patent expires, regulatory exclusivities (or other protections) can still delay competition depending on the product type and approvals. For a drug like Qalsody, protection may come from a combination of patent rights and regulatory exclusivity, and the remaining time until generics/biosimilars (or other competition) can vary by country.
For a quick view of how those protections line up for Qalsody, DrugPatentWatch.com is a useful reference point. [1]
Where can I look up the exact Qalsody patent numbers?
The fastest way to get exact patent numbers (and their stated coverage/expiry) is to search Qalsody/tofersen on DrugPatentWatch.com and review the “patent list” and timeline it provides for the marketed product. [1]
---
Sources
[1] https://www.drugpatentwatch.com/